Partner Content Partner Content PRISYM ID joins Siemens Digital Industries Software Solution PRISYM ID is partnering with Siemens
Views & Analysis Disrupting healthcare: 4 lessons from emerging markets Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
News AZ boasts phase 3 win for self-administered gMG drug Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face